Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) EBITDA (2016 - 2025)

Historic EBITDA for Dentsply Sirona (XRAY) over the last 17 years, with Q3 2025 value amounting to -$218.0 million.

  • Dentsply Sirona's EBITDA rose 5281.39% to -$218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$792.0 million, marking a year-over-year decrease of 16666.67%. This contributed to the annual value of -$879.0 million for FY2024, which is 93411.76% down from last year.
  • Per Dentsply Sirona's latest filing, its EBITDA stood at -$218.0 million for Q3 2025, which was up 5281.39% from -$128.0 million recorded in Q2 2025.
  • Over the past 5 years, Dentsply Sirona's EBITDA peaked at $172.0 million during Q4 2021, and registered a low of -$1.2 billion during Q3 2022.
  • For the 5-year period, Dentsply Sirona's EBITDA averaged around -$82.9 million, with its median value being $63.0 million (2025).
  • Per our database at Business Quant, Dentsply Sirona's EBITDA tumbled by 102272.73% in 2022 and then surged by 220000.0% in 2024.
  • Dentsply Sirona's EBITDA (Quarter) stood at $172.0 million in 2021, then tumbled by 62.21% to $65.0 million in 2022, then rose by 12.31% to $73.0 million in 2023, then plummeted by 797.26% to -$509.0 million in 2024, then surged by 57.17% to -$218.0 million in 2025.
  • Its last three reported values are -$218.0 million in Q3 2025, -$128.0 million for Q2 2025, and $63.0 million during Q1 2025.